Hadden RDM, Marreno F. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Ther Adv Neurol Disord. 2015;8(1):14-19.
Markvardsen LH, Debost JC, Harbo T, et al. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2013;20(5):836-842.
Berger M. Subcutaneous IgG in neurologic diseases. Immunotherapy. 2014;6(1):71-83.
Data on File. Available from CSL Behring as DOF HIZ-005.
van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomised double-blind placebo-controlled trial: the PATH Study. Lancet Neurol. 2017;17(1):35-46.
Hagan JB, Fasano MB, Spector S, et al. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency. J Clin Immunol. 2010;30(5):734-745.
Jolles S, Borte M, Nelson R, et al. Long-term efficacy, safety, and tolerability of Hizentra for treatment of primary immunodeficiency disease. Clin Immunol. 2014;150(2):161-169.
Data on File. Available from CSL Behring as DOF HIZ-006.
Wasserman RL, Melamed I, Nelson RP Jr, et al. Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency. Clin Pharmacokinet. 2011;50(6):405-414.
National Center for Health Statistics (US Department of Health and Human Services) International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). 2021 Codes Tables and Index. https://www.cdc.gov/nchs/icd/icd10cm.htm. Accessed June 25, 2021.
2021 CPT Code 96369. American Academy of Professional Coders website. https://www.aapc.com/codes/cpt-codes/96369. Accessed June 25, 2021.
Centers for Medicare and Medicaid Services (US Department of Health and Human Services). HCPCS Release and Code Sets. https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update. Accessed June 25, 2021.
Murphy E, Burton J, Riley P. Nursing approaches to a novel subcutaneous immunoglobulin therapy. Infusion. 2007;13:1-8.
Van Schaik IN, Orell N, Bril V, et al. Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP. Neural Neuroimmunol Neuroinflamm. 2019;6:e590.
2021 CPT Code 96370. American Academy of Professional Coders website. https://www.aapc.com/codes/cpt-codes/96370. Accessed June 25, 2021.
2021 CPT Code 96371. American Academy of Professional Coders website. https://www.aapc.com/codes/cpt-codes/96371. Accessed June 25, 2021.
2021 HCPCS Code S9338. American Academy of Professional Coders website. https://www.aapc.com/codes/hcpcs-codes/S9338. Accessed June 25, 2021.
Centers for Medicare and Medicaid Services (US Department of Health and Human Services) Medicare Learning Network. Billing for Home Infusion Therapy Services. https://www.cms.gov/files/document/MM11880.pdf. Accessed June 25, 2021.
Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Eur J Neurol. 2021;1‐28. https://doi.org/10.1111/ene.14959.
